Tracking gist cases worldwide for better care
Part of Cancer, Digestive system clinical trials.
This study is a large registry that collects information from people with GIST (a rare tumor in the digestive tract) across many countries. By joining, you help doctors learn more about the disease and how to treat it, which may benefit you and others in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a GIST (a type of tumor in the digestive tract).
- You are able to give both verbal and written consent to participate.
- You are physically and mentally able to understand what the study involves.
- You do not have a severe mental or neurological condition that would prevent you from giving informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have been taking targeted cancer drugs (called TKIs) for advanced GIST for at least 2 years to understand how these long-term treatments affect quality of life, side effects, and daily living. Researchers want to learn what challenges patients face and how to better support them.
This study is creating a registry to track people with GIST over time. Participating helps researchers learn more about the disease and improve future care.
This trial tests a new drug called NB003 for people with advanced GIST (a type of stomach or intestinal tumor) that has stopped responding to or could not be tolerated after standard treatments like imatinib or sunitinib. The goal is to see if NB003 can help shrink or control the tumor.
This trial tests the safety of using a robot to remove small stomach tumors (GISTs) that are in hard-to-reach places. It aims to see if robotic surgery is a good option for you.
This study looks at why some GIST tumors stop responding to standard treatments. It uses special imaging and genetic testing of tumor tissue to find resistance patterns, which may guide future treatment choices.
This study looks at how surgery for gastrointestinal stromal tumors (GIST) works, and collects tumor samples to study them under the microscope and by DNA testing. Your results may help researchers better predict tumor behavior and guide future treatment.
Hear when a new Gastrointenstinal Stromal Tumor (GIST) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.